Open AccessRESIDUAL PLATELET REACTIVITY TO ADP AND THE RISK OF BLEEDING IN STABLE CHD PATIENTS RECEIVING DOUBLE ANTIPLATELET THERAPY FOR ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
Author(s) -
E. V. Guskova,
Е. П. Панченко,
A. L. Komarov,
A. B. Dobrovolsky,
A. N. Samko
Publication year - 2015
Publication title -
rossijskij kardiologičeskij žurnal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.141
H-Index - 14
eISSN - 2618-7620
pISSN - 1560-4071
DOI - 10.15829/1560-4071-2015-2-35-42
Subject(s) - clopidogrel , medicine , conventional pci , percutaneous coronary intervention , aspirin , p2y12 , cyp2c19 , cardiology , ticlopidine , residual risk , revascularization , myocardial infarction , metabolism , cytochrome p450